
Serum procalcitonin levels in chronic obstructive pulmonary disease patients in North Indian Population
Author(s) -
Sushma Pandey,
Rajiv Garg,
Surya Kant,
Ajay Kumar Verma,
Priyanka Gaur
Publication year - 2019
Publication title -
annals of african medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.433
H-Index - 26
ISSN - 1596-3519
DOI - 10.4103/aam.aam_44_18
Subject(s) - medicine , procalcitonin , copd , exacerbation , pulmonary disease , biomarker , population , gastroenterology , sepsis , biochemistry , chemistry , environmental health
Exacerbations in Chronic obstructive pulmonary disease (COPD) have a considerable impact on morbidity, mortality, and quality of life. Procalcitonin (PCT) a polypeptide normally produced in neuroendocrine cells of the thyroid and lungs is a marker of systemic inflammation and bacterial infection.